Literature DB >> 25155595

The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Ana Cecilia Mesa-Arango1, Nuria Trevijano-Contador2, Elvira Román3, Ruth Sánchez-Fresneda4, Celia Casas5, Enrique Herrero5, Juan Carlos Argüelles4, Jesús Pla3, Manuel Cuenca-Estrella2, Oscar Zaragoza6.   

Abstract

Amphotericin B (AMB) is an antifungal drug that binds to ergosterol and forms pores at the cell membrane, causing the loss of ions. In addition, AMB induces the accumulation of reactive oxygen species (ROS), and although these molecules have multiple deleterious effects on fungal cells, their specific role in the action mechanism of AMB remains unknown. In this work, we studied the role of ROS in the action mechanism of AMB. We determined the intracellular induction of ROS in 44 isolates of different pathogenic yeast species (Candida albicans, Candida parapsilosis, Candida glabrata, Candida tropicalis, Candida krusei, Cryptococcus neoformans, and Cryptococcus gattii). We also characterized the production of ROS in AMB-resistant isolates. We found that AMB induces the formation of ROS in all the species tested. The inhibition of the mitochondrial respiratory chain by rotenone blocked the induction of ROS by AMB and provided protection from the killing action of the antifungal. Moreover, this phenomenon was absent in strains that displayed resistance to AMB. These strains showed an alteration in the respiration rate and mitochondrial membrane potential and also had higher catalase activity than that of the AMB-susceptible strains. Consistently, AMB failed to induce protein carbonylation in the resistant strains. Our data demonstrate that the production of ROS by AMB is a universal and important action mechanism that is correlated with the fungicidal effect and might explain the low rate of resistance to the molecule. Finally, these data provide an opportunity to design new strategies to improve the efficacy of this antifungal.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25155595      PMCID: PMC4249417          DOI: 10.1128/AAC.03570-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  92 in total

Review 1.  Synthesis and biological evaluation of amphotericin B derivatives.

Authors:  Astrid A Volmer; Alex M Szpilman; Erick M Carreira
Journal:  Nat Prod Rep       Date:  2010-06-16       Impact factor: 13.423

2.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

3.  Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria.

Authors:  R A Woods; M Bard; I E Jackson; D J Drutz
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

4.  Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis.

Authors:  E Dannaoui; E Borel; F Persat; M A Piens; S Picot
Journal:  J Med Microbiol       Date:  2000-07       Impact factor: 2.472

Review 5.  Amphotericin B nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

6.  In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus.

Authors:  G Blum; B Kainzner; K Grif; H Dietrich; B Zeiger; T Sonnweber; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2012-04-19       Impact factor: 8.067

7.  Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.

Authors:  Jesús Guinea; Óscar Zaragoza; Pilar Escribano; Estrella Martín-Mazuelos; Javier Pemán; Ferrán Sánchez-Reus; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 8.  Pharmacotherapy of yeast infections.

Authors:  Alicia Gómez-López; Oscar Zaragoza; Juan Luis Rodríguez-Tudela; Manuel Cuenca-Estrella
Journal:  Expert Opin Pharmacother       Date:  2008-11       Impact factor: 3.889

9.  Effects of ascorbic acid on the antifungal action of amphotericin B.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; G Medoff
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

10.  Potentiation of antibiofilm activity of amphotericin B by superoxide dismutase inhibition.

Authors:  Katrijn De Brucker; Anna Bink; Els Meert; Bruno P A Cammue; Karin Thevissen
Journal:  Oxid Med Cell Longev       Date:  2013-09-01       Impact factor: 6.543

View more
  60 in total

1.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  Macrolides Inhibit Capsule Formation of Highly Virulent Cryptococcus gattii and Promote Innate Immune Susceptibility.

Authors:  Shigeki Nakamura; Yurika Ikeda-Dantsuji; Lianjin Jin; Yoshitsugu Higashi; Masahiro Abe; Tatsuya Inukai; Minoru Nagi; Makoto Urai; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.

Authors:  Suélen Andreia Rossi; Haroldo Cesar de Oliveira; Daniel Agreda-Mellon; José Lucio; Maria José Soares Mendes-Giannini; Jesús Pablo García-Cambero; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance.

Authors:  Emina Jukic; Michael Blatzer; Wilfried Posch; Marion Steger; Ulrike Binder; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 5.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

6.  Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.

Authors:  Elena Shekhova; Olaf Kniemeyer; Axel A Brakhage
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  Comparative Ploidy Proteomics of Candida albicans Biofilms Unraveled the Role of the AHP1 Gene in the Biofilm Persistence Against Amphotericin B.

Authors:  Thuyen Truong; Guisheng Zeng; Lin Qingsong; Lim Teck Kwang; Cao Tong; Fong Yee Chan; Yue Wang; Chaminda Jayampath Seneviratne
Journal:  Mol Cell Proteomics       Date:  2016-09-19       Impact factor: 5.911

Review 8.  Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility.

Authors:  Nina T Grossman; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans.

Authors:  Fabiana Freire M Oliveira; Hugo Costa Paes; Luísa Defranco F Peconick; Fernanda L Fonseca; Clara Luna Freitas Marina; Anamélia Lorenzetti Bocca; Mauricio Homem-de-Mello; Márcio Lourenço Rodrigues; Patrícia Albuquerque; André Moraes Nicola; J Andrew Alspaugh; Maria Sueli S Felipe; Larissa Fernandes
Journal:  Fungal Genet Biol       Date:  2020-03-19       Impact factor: 3.495

Review 10.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.